Study summary

An aldosterone synthase blocker lowered hard-to-treat blood pressure

BaxHTN trial (baxdrostat) · 796 people, phase 3 · Published October 2025, New England Journal of Medicine

15.7mm Hg drop in systolic blood pressure with 2 mg, vs 5.8 with placebo

What was tested

Baxdrostat, a pill that blocks the body from making aldosterone, against placebo in uncontrolled or resistant high blood pressure. The same drug class as vicadrostat, now tested in diabetes.

What they found

What it means

Aldosterone synthase inhibitors are being tested to protect the heart and kidneys in diabetes.

N Engl J Med, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.